We have shown in genetic myopathic hamsters that cardiac myofibrillar ATPase regulation by calcium is altered and that there are shifts in myosin isozyme distribution (V1->V3) suggesting abnormalities in multiple components of the contractile apparatus. To focus more on the regulatory proteins (troponin and tropomyosin), individual proteins of the skeletal and cardiac actomyosin system were reconstituted under controlled conditions. In this way, myosin plus actin and troponin-tropomyosin from the normal and myopathic animals could be studied enzymatically. The proteins were isolated from the skeletal or cardiac muscle of random-bred control and cardiomyopathic hamsters (BIO 53:58) [Tm]) are responsible, in part, for transducing the effect of free calcium in contractile protein activation and for inhibiting this activity when calcium is absent. Tn-Tm (also called relaxing factor",2) forms a key protein complex for the control of muscular contraction. Under relaxing conditions, these proteins inhibit the substrate (ATP)-driven actomyosin cycle either by blocking the attachment of myosin cross bridges to actin3,4 or by inhibiting subsequent reactions of the bound cross bridge.5 The whole Ca21 -sensitive complex is made up of three nonidentical Tn subunits: 1) troponin T (TnT; tropomyosin-binding unit), 2) troponin I (Tnl; inhibitory unit), 3) troponin C (TnC; Ca2-binding sub-
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We have shown in genetic myopathic hamsters that cardiac myofibrillar ATPase regulation by calcium is altered and that there are shifts in myosin isozyme distribution (V1->V3) suggesting abnormalities in multiple components of the contractile apparatus. To focus more on the regulatory proteins (troponin and tropomyosin), individual proteins of the skeletal and cardiac actomyosin system were reconstituted under controlled conditions. In this way, myosin plus actin and troponin-tropomyosin from the normal and myopathic animals could be studied enzymatically. The proteins were isolated from the skeletal or cardiac muscle of random-bred control and cardiomyopathic hamsters (BIO 53:58) at 7 months of age. Sodium dodecyl sulfate gel electrophoretic patterns indicated differences in the troponin I and troponin C regions of myopathic skeletal muscle, but cardiac samples from control and myopathic hamsters showed similarities in their mobilities. This suggests the possibility of different cardiac isozymes in the regulatory protein complex, as reported in our previous studies of cardiac myosin in cardiomyopathy. Calcium sensitivity was markedly decreased in the actomyosin reconstituted with troponin-tropomyosin from skeletal as well as cardiac muscle from myopathic animals. In summary, our data show that the regulatory proteins in skeletal and cardiac muscle of the myopathic hamsters have decreased inhibitory action on Mg2`-actomyosin ATPase activity.
This loss of calcium regulation along with shifts in cardiac myosin heavy chain may be partially responsible for the impaired cardiac function in the hearts of myopathic hamsters. (Circulation Research 1990; 66:1302 -1309 In vertebrate striated muscle, regulatory components of the thin filaments (troponin [Tn] and tropomyosin [Tm] ) are responsible, in part, for transducing the effect of free calcium in contractile protein activation and for inhibiting this activity when calcium is absent. Tn-Tm (also called relaxing factor",2) forms a key protein complex for the control of muscular contraction. Under relaxing conditions, these proteins inhibit the substrate (ATP)-driven actomyosin cycle either by blocking the attachment of myosin cross bridges to actin3,4 or by inhibiting subsequent reactions of the bound cross bridge. 5 The whole Ca21 -sensitive complex is made up of three nonidentical Tn subunits: 1) troponin T (TnT; tropomyosin-binding unit), 2) troponin I (Tnl; inhibitory unit), 3) troponin C (TnC; Ca2-binding sub-unit) plus tropomyosin. The properties of Tn subunits that cause binding with Tm to form an actinlinked calcium-sensitive regulatory system in skeletal and cardiac muscle contraction in different pathological and physiological models are quite unclear. The relative properties of fast and slow skeletal TnT are subject to neural, hormonal, and developmental influences.6-8 To date, three major isoforms of TnI that exist in cardiac tissue and in fast and slow skeletal muscle have been detected.9"10 In thyroidectomy, for example, it has been suggested that thyroid hormones can directly alter the expression of the genes controlling the synthesis of the components of the Tn complex in the absence of an active nerve." Differences in fast and slow skeletal and cardiac TnT have also been described under various conditions.'2-16 Immunochemical studies on the polymorphic forms of TnT and TnC and their localization in striated muscle cell types have demonstrated that TnC in fast skeletal muscle differs from TnC present in slow skeletal and cardiac muscle cells.12 Besides the presence of multiple forms of Tn subunits in different muscles, the existence of different isomorphs of tropomyosin (a and P3) is well established.
In skeletal muscle, two different types of Tm have been reported, whereas a-Tm predominantly exists in the cardiac muscle of mammalian species. Tm from different tissues or species exhibits similarities in a number of physical, chemical, and functional properties.17 '18 In a study on the regulatory proteins of the myocardium, Humphreys and Cummins10 suggested that developmental transitions were associated with altering Tm subunit expression. Recently, an extensive review19 of the role of Tm and Tn in the regulation of skeletal muscle contraction has been published describing the molecular mechanisms involved in the contractile regulation. Little is known about the role of the Tn-Tm in the regulation of skeletal and cardiac muscle in various pathological and physiological states.
Using electrophoretic and immunoelectrophoretic techniques, Obinata et a120 demonstrated that the types of Tnl vary in developing normal and dystrophic chicken skeletal muscle. In another study Toyooka and Ross21 reported that the loss of Ca21 sensitivity of natural actomyosin, which was prepared from myocardium undergoing infarction after coronary occlusion, could be attributed to the destruction of regulatory proteins. Alterations in Tn subunits were also observed by the analysis of the Tn-Tm complex during myocardial infarction in the dog heart.22 Studies from our laboratory23 on isolated purified cardiac myofibrils from cardiomyopathic Syrian hamsters suggest that the regulatory control of contractile proteins may be altered in these animals. To further elaborate on the contributory role of Tn-Tm in the cardiomyopathic hamsters, hybridization studies were performed in the present study by cross-reacting skeletal or cardiac myosin with skeletal or cardiac relaxing factor (Tn-Tm) from control or myopathic animals at 7 months of age. Sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) profiles indicated differences in the Tn-Tm complex isolated from control compared with myopathic skeletal muscle, but the electrophoretic mobilities of cardiac Tn-Tm from the control and myopathic hamsters were similar. Tn-Tm of cardiac or skeletal muscle from myopathic hamsters showed a loss in Ca21 sensitivity when compared with skeletal or cardiac actomyosin from normal animals. hearts and samples of mixed skeletal (fast and slow) muscle were removed. After washing the hearts, the atria and great vessels were removed, and a homogenizer (Tekmar, Cincinnati, Ohio) was used for homogenization of the whole ventricular portions. Twentyfive to 30 hearts (10 g) were pooled in each group for purification of cardiac regulatory proteins. Muscle tissue (50 g) from the back and leg was used for skeletal regulatory proteins. All the tissues were frozen and stored at -70°C in 50% glycerol containing (mM) KCI 30, KPO4 10 (pH 7.0), and ,3-mercaptoethanol 5 before the preparation of different proteins. There was no difference in actomyosin-ATPase activity if hearts were prepared immediately or after a period of storage.
Preparation of Proteins
Cardiac myosin from normal mongrel dogs, Wistar rats, and random-bred control and myopathic hamsters was prepared by methods previously described. 24 Actin was extracted and purified from rabbit skeletal muscle acetone powder. 25 
Troponin and Tropomyosin
The Tn-Tm complex was prepared by a slight modification of the methods of Eisenberg and Kielley26 and Potter.27 In all the preparations, various proteolytic enzyme inhibitors, such as PMSF (0.1-0.2 mM), leupeptin (1 ,ug/ml), pepstatin (1 gg/ml), and TLCK (0.1 mM), were used.
Briefly, skeletal muscle (50 g) or cardiac tissue (10 g) was minced and homogenized with 10 vol of 0.05 M KCI and 0.01 M KPO4 (pH 7.0) with 1 mM DTT and centrifuged. The pellets, which consisted of crude myofibrils, were further treated with 0.05 M KCl, 0.01 M KPO4 (pH 7.0), and 2 mM EGTA (pH 7.0), followed by washing with buffer containing 0.1% Triton X-100. Myofibrils washed with Triton X-100 were extracted briefly with KCl-pyrophosphate buffer containing (M) KCI 0. Figure 1 shows the representative SDS gradient slab gel electrophoretic patterns and the densitometric scans of the Tn-Tm complex isolated from the skeletal muscle of control and myopathic hamsters. Coelectrophoresis and scans of the Tn-Tm complex, (6) Figure 1 ) in the myopathic sample when compared with the control sample. SDS-PAGE and densitometric scans of cardiac Tn-Tm complex are shown in Figure 2 ; similar patterns occur in control and myopathic samples of cardiac regulatory protein preparations with no evidence of any other additional bands. However, very small changes were visible in the region of TnI and TnC in the cardiac Tn-Tm complex.
To check the viability of the Tn-Tm complex in regulating the actomyosin-ATPase activity in the hamster muscle study, initial studies were focused on the regulatory complex isolated from the myocardium of two different normal mammalian species (dog and rat). Figure 3 shows the regulated actomyosin sigmoid curves for normal dog and rat cardiac actomyosin, which was reconstituted with normal dog and rat cardiac regulatory proteins at increasing free Ca' ion concentrations. The ATPase activity, with and without calcium present, demonstrated the viability and regulation of actomyosin-ATPase by the Tn-Tm complex in the cardiac muscles. Table 1 presents the Ca2',Mg2+-ATPase activity of reconstituted skeletal actomyosin from control and myopathic hamsters at 7 months of age. As shown in the table, actomyosin-ATPase was also studied at higher molar ratios of actin: the Tn-Tm complex with myosin. Results were similar in the two sets of studies. The data demonstrate a loss of the inhibitory effect of EGTA (removal of Ca>2) in the presence of relaxing factor (Tn-Tm) from myopathic hamsters mixed with myosin from either control or myopathic hamsters. Actomyosin from control hamsters that was recombined with regulatory proteins (Tn-Tm) from myopathic hamsters had a 23-29% depression of Ca>, Mg2+-ATPase activity when compared with the Ca2+,Mg2+-ATPase activity of actomyosin from control hamsters measured in the presence of relaxing factor (Tn-Tm) from control hamsters. Table 2 tion was diminished to 44-51% when myosin from control hamsters was reassociated with cardiac relaxing factor extracted from myopathic hamsters. Figure   4 shows the Ca2'-dependent skeletal actomyosinATPase activity using control myosin in the presence of control or myopathic skeletal regulatory complex.
The basal Mg29-ATPase (EGTA-ATPase) of actomyosin was significantly elevated with myopathic relaxing factor, but the overall activation by free calcium in the range of 1 ,uM-0.1 mM was slightly decreased when control myosin was reconstituted with myopathic relaxing factor. Figure 5 shows Ca2' dose- Figure 6 . Data from dog and rat cardiac muscles (III and IV, respectively, in Figure 6 ) are shown as normal controls for comparisons. Random Table 1 . In group A, the weight ratio of reconstituted actomyosin with Tn-Tm was 2: 1: 1 (myosin: actin: Tn-Tm); in group B, the ratio was 4: 3:3 (myosin: actin: Tn-Tm). Tn-Tm complex was calculated on the basis of its 90% purity by gels. *p<0.05 when comparing groups 1-4 for Ca2'-ATPase, EGTA-ATPase, or percent inhibition, respectively. CARD.
-I-- paratus.23 Because of the complex nature and protein isoform heterogeneity of myofibrillar contractile machinery, the present study was designed to compare the regulated actomyosin system by isolating and purifyinig the different proteins and then recombining theni under controlled conditions. In this way, the role of mnyosin and the Tn-Tm complex in control and experirnental animals could be studied independently. We report alterations in the regulatory proteins based on the enzymatic analysis of actomyosin conducted in the presence of the Tn-Tm complex isolated from the skeletal or cardiac muscle of cardiomyopatlbic hamsters at 7 months of age. Figure 1 ). The phosphorylation of TnI appears to influence the regulation of cardiac myofibrils; it has been proposed by Robertson et a134 that TnI phosphorylation reduces the amount of myofibrillar bound Ca21 over the same pCa range at which myofibrillar ATPase is activated by Ca2. This suggests that TnI phosphorylation most likely alters the Ca2 binding properties of TnC. The conditions of our extraction procedure make it highly unlikely for the different proteins isolated to be in a phosphorylated state. In the present study, the Tn-Tm complex analyzed by slab gel electrophoresis showed that Tn subunits on gradient gels were more visibly reduced in skeletal myopathic muscle than in random-bred control muscle. One of the possible explanations in our study could be that TnI and TnC are lower in content in myopathic skeletal muscle than in control skeletal muscle, as seen on SDS gradient slab gels; another explanation could be that TnI and TnC are degraded by one or multiple proteases in vivo or in vitro. We and others have previously reported the presence of an alkaline protease24 and Ca2 activated proteases35 present in the myopathic hamster muscle. To our knowledge, the breakdown of one or more of the subunits of the regulatory protein complex in myopathic muscles during isolation and purification in the present study would be unlikely because several protease inhibitors were present throughout our preparative procedures. To support the above explanation, Tn-Tm was prepared from the random-bred control and myopathic muscles at the same time under the same experimental conditions.
Regulatory proteins from the cardiac muscle of myopathic animals and random-bred controls had similar mobility on SDS slab gels except in the TnI and TnC regions, where very small changes may be present. Thus, the loss in sensitivity in the myopathic hamster hearts may be explained by either different contents of Tn-Tm subunits present or different isozymic forms of these regulatory protein subunits. Quantitative estimation of the Tn-Tm complex contents ruled out any differences in regulatory protein subunit content (data not shown) from control and myopathic hearts. Thus, the different makeup of isozymic forms in the regulatory complex may be a more likely explanation.
In conclusion, SDS-PAGE patterns of skeletal Tn-Tm complex from control and experimental muscles in dystrophic hamsters at 7 months of age were indicative of differences in the TnI and TnC regions. However, in cardiac muscle, SDS 
